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Abstract
Introduction: Several	studies	have	investigated	different	tools	for	asthma	diagnosis	in	order	to	reduce	the	cost	and	improve	its	
early	recognition.	The	goal	of	this	study	is	to	establish	a short	questionnaire	to	be	used	in	practice	for	asthma	screening	and	
compare	diagnostic	values	between	this	method	and	spirometric	response	to	bronchodilators.
Material and method: 208	patients	presenting	with	chronic	stable	dyspnea	 (>	6	months)	and	definite	clinical	diagnosis	of	
chronic	obstructive	pulmonary	disease,	bronchiectasis,	pulmonary	fibrosis	or	asthma,	were	enrolled.	9	questions	out	of	43	based	
on	the	literature	search	were	selected by	regression	analysis.	Patients	were	asked	to	complete	the	questionnaire	and	then	their	
spirometric	responses	to	bronchodilators	were	evaluated.	
Results: Of	all,	53.8%	of	cases	were	diagnosed	clinically	to	have	asthma.	For	establishing	diagnosis	of	asthma,	the	bronchodilator	
test	had	48.2%	sensitivity,	78.1%	specificity,	72%	positive,	56.4%	negative	predictive	values,	2.2	positive,	0.66	negative	likeli-
hood	ratios,	and	false	positive,	false	negative	and	accuracy	of	21.9%,	51.8%	and	62.01%,	respectively.	The	revised	9	questions	
from	the	questionnaire	had	97.3%	sensitivity,	77.1%	specificity,	83.2%	positive,	96.1%	negative	predictive	values,	4.24	positive,	
0.03	negative	likelihood	ratios,	22.9%	false	positive,	2.7%	false	negative	and	87.98%	accuracy.
Conclusions: The	9-question	questionnaire	had	better	diagnostic	values	in	defining	asthma	in	patients	with	chronic	dyspnea	than	
reversibility	of	airway	obstruction	to	salbutamol	and	can	be	used	as	a useful	screening	test	for	diagnosis	of	asthma	in	clinical	
practice	and	for	investigational	purposes.
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Introduction
Asthma is a commonly encountered disorder 
that imposes a great burden on patients and the-
ir family members if not diagnosed and treated 
properly. Its misdiagnosis causes a  great cost 
for patients, health care institutions and local 
or national health service. On the other hand, 
asthma’s definite pathophysiology is not clearly 
known so far, thus current diagnosis is based on 
signs and symptoms, and objective pulmonary 
function evaluations [1−4]. Spirometry is not 
available in all institutions, and it needs pa-
tient’s cooperation. There are some reports that 
confirm the reversibility of airway obstruction in 
response to short-acting bronchodilators, which 
is one of the inclusion criteria for diagnosis of 
asthma, cannot be seen in some patients suffering 
from asthma. Moreover, limited reversibility of 
the airways is present in some other respiratory 
disorders, which must be included in differential 
diagnosis of asthma. Hence, spirometry is not 
Advances in Respiratory Medicine 2019, vol. 87, no. 5, pages 269–275
270 www.journals.viamedica.pl
a definite test for diagnosis of asthma [5−9]. The-
re are several studies published till date which 
have investigated different tools with sufficient 
sensitivity and specificity in order to reduce the 
cost of recognition of asthma and to be applicable 
in clinical practice all around the world.
Similar investigations into chronic obstruc-
tive pulmonary disease (COPD) showed that 
brief questionnaires are valuable in differen-
tiating COPD from other pulmonary disorders 
as screening tools in primary health care cen-
ters [10, 11]. Also, there are various surveys in 
which asthma was defined by a questionnaire, 
but none of them were used in clinical practice. 
So, in this study, our efforts went into designing 
a practical and appropriate questionnaire for 
asthma screening which can be applicable in 
other primary health care units. We assessed other 
questionnaires and the usage of our clinical expe-
riences. Also, we compared its diagnostic power 
to response to bronchodilators in spirometry. 
Material and methods
213 patients from the outpatient pulmonary 
clinic of Masih Daneshvari Hospital who had hi-
story of chronic dyspnea for more than 6 months 
and consented to enroll in the study, were assi-
gned for the research. All subjects were examined 
by a pulmonologist and their asthma was defi-
ned in line with the GINA (Global Initiative for 
Asthma) [2] and the Saudi Initiative for Asthma 
[12] guidelines. Other respiratory disorders like 
COPD, pulmonary fibrosis and bronchiectasis 
were confirmed by history, physical examination 
and chest radiographies. Then, each patient was 
interviewed and assessed for airway reversibility 
by spirometry before and 20 minutes after inha-
lation of 4 puffs (400 μ) of salbutamol as a short- 
-acting bronchodilator through a spacer [2, 12, 13].
Exclusion criteria:
— exacerbation of disease which induced chro-
nic cough such as COPD, bronchiectasis or 
asthma;
— inability to perform the spirometry properly;
— disagreement on continuing the research;
— probability of Mycobacterium tuberculosis 
infection based on symptoms or radiological 
findings;
— past history of hypersensitivity to salbutamol;
— patients without definite diagnosis accor-
ding to the clinical evaluation for reason of 
chronic cough by a pulmonologist (as the 
gold standard to differentiate asthma or non-
-asthma in the disease groups).
5 patients met the exclusion criteria, hence 
were excluded from the study and the research 
continued with 208 patients who complied with 
the inclusion criteria. Data were collected and 
used for statistical analysis.
Airway reversibility: FEV1 (forced expiratory 
volume in one second) increased by ≥ 12% and 
≥ 200 mL, 20 minutes after inhalation of bron-
chodilator [2, 12, 13].
Statistical analysis
Data were analyzed by SPSS® 16 (Statistical 
Package for the Social Science, for Windows, 
Chicago. Version 16) software with using the 
Chi2, ANOVA, independent T-test and linear 
regression to reveal independent associations 
between questions and the study groups. Further 
analysis such as receiver operating characteristic 
(ROC) curve used to determine a cut-off point 
for diagnosis of asthma by questionnaire EPI® 
6 was applied for its good sensitivity, specifici-
ty, positive/negative predictive value, positive/ 
/negative likelihood ratio and accuracy analysis. 
Significant level for a and b errors were 0.05 and 
0.2, respectively.
Questionnaire
The initial questionnaire was designed by 
selecting questions according to symptoms, signs 
or complaints about diseases accompanied by 
chronic cough, which had the best sensitivity 
and specificity in establishing the diagnosis of 
asthma in previous studies (Table 1). Then the 
43 items questionnaire (arranged in 26 questions) 
was reviewed by a group of experienced pulmo-
nologists in Masih Daneshvari hospital (center of 
excellence in lung diseases in Iran) for content 
and validity. The study was approved by the Na-
tional Research Institute of Tuberculosis and Lung 
Diseases (NRITLD) research committee (approval 
code: CRD9010).
All visits and interviews were performed 
by 3 trained counselors who were blinded for 
type of disease and the spirometry results. The 
standardized Cronbach’s alpha, which measures 
the internal consistency of the components of 
a score, was 0.83 for the questionnaire (43 items). 
Regression analysis was performed on the initial 
questionnaire, and 9 out of 43 questions with 
independently significant correlation with asthma 
were described. So, the 9-question questionnaire 
(9-QQ) was adopted and correlation coefficients 
were used for questionnaire scoring (Table 2) 
and other types of analysis. We used both spiro-
metric bronchodilator response and the 9-QQ as 
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Table 1. Complete questionnaire for determining asthma in patients with chronic dyspnea
1.		 Does	your	chest	ever	sound	wheezy	or	whistling? Yes	 No	
2.		 Does	your	chest	ever	sound	wheezy	or	whistling,	during	last	12	months? Yes	 No	
3.		 How	many	times	does	your	chest	ever	sound	wheezy	or	whistling	during	last	12	months?
	 Not	ever		 	1−3	times		 	4−12	times		 	>	12	times	
4.		 Have	you	ever	woken	up	with	a	feeling	of	tightness	in	your	chest	first	thing	in	the	morning?	 Yes	 No	
5.		 Have	you	ever	woken	up	with	a	feeling	of	tightness	in	your	chest	first	thing	in	the	morning	in	the	last	12	
months?
Yes	 No	
6.		 Have	you	ever	had	a	feeling	of	tightness	in	your	chest	that	came	on	after	you	stopped	exercising? Yes	 No	
7.		 Have	you	ever	had	a	feeling	of	tightness	in	your	chest	that	came	on	after	you	stopped	exercising	in	the	last	
12	months?
Yes	 No	
8.		 Have	you	ever	had	a	period	of	being	well	without	any	symptoms? Yes	 No	
9.		 Have	you	ever	had	asthma	in	your	opinion? Yes	 No	
10.	Has	a	doctor	ever	told	you	that	you	have	asthma? Yes	 No	
11.	Are	your	symptoms	occur	or	worsen	at	night? Yes	 No	
12.	Have	you	ever	been	woken	at	night	by	an	attack	of	symptoms? Yes	 No	
13.	How	many	times	you	been	woken	at	night	by	an	attack	of	shortness	of	breath/cough	during	last	12	months?																																																						
	 Not	ever													<	1	night	per	week												>	1	night	per	week	
14.	Have	you	ever	had	severe	dyspnea	as	could	not	speech	more	than	2	words	between	your	breaths	during	
last	12	months?
Yes	 No	
15.	Are	your	symptoms	occur	or	worsen	in	a	seasonal	pattern? Yes	 No	
16.	If	yes	to	15,	in	which	seasons?																			Spring															Summer														Autumn											Winter		
17.	Have	you	ever	had	history	of	eczema,	hay	fever,	dermatitis	or	atopic	disease? Yes	 No	
18.	Have	you	ever	had	first	degree	family	history	of	eczema,	hay	fever,	dermatitis	or	atopic	disease? Yes	 No	
19.	Are	your	symptoms	relief	by	anti-asthma	therapy	(salbutamol	inhaler)?					Not	used		 Yes	 No	
20.	Are	your	colds	take	more	than	10	days	to	clear	up? Yes	 No	
21.	Are	your	colds	go	to	the	chest? Yes	 No	
22.	Have	you	ever	had	history	of	the	any	following?
Recurrent	coughs	
Recurrent	wheeze	
Recurrent	difficult	breathing	
Recurrent	chest	tightness	
23.	Have	your	symptoms	occur	or	worsen	in	the	presence	of:
	 Animals	with	fur	
	 Aerosol	chemicals	
	 Domestic	dust	mites	
	 Chang	in	temperature	
Drugs	(aspirin,	beta	blockers)	
Respiratory	(viral)	infections	
Strong	emotional	expression	
Smells	(perfumes,	foods…)	
Pollen	
Exercise	
Cigarette	smoke	
Vehicles	smoke	
24.	Have	you	ever	had	cough	and	phlegm	more	than	3	months	per	year	in	more	than	2	years? Yes	 No	
25.	Do	you	often	have	exertional	dyspnea? Yes	 No	
a combined screening test for more research, and 
in this setting asthma diagnosis was made when 
both tests were positive.
Results
208 patients with chronic dyspnea who visited 
pulmonary clinics of our center during 9 months 
were enrolled in the study. Demographic charac-
teristics of the study cohort are listed in Table 3. 
54 asthmatic cases (48.2%) and 21 non-asth-
matic individuals (21.9%) had positive airway 
response to bronchodilator (P-value < 0.001). In 
10 (20.8%) cases with bronchiectasis, 1 (8.3%) 
with pulmonary fibrosis and 10 (27.8%) patients 
with COPD from non-asthmatic patients airway 
reversibility with bronchodilators were noted. 
Regression analysis between a  type of disease 
and questionnaire questions revealed that only 
9 out of 43 questions had independent association. 
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Table 2. 9-question screening questionnaire for determining asthma in patients with chronic dyspnea
Question   Yes*    No*
1.	Have	you	ever	had	a	period	of	being	well	without	any	symptoms? +0.218 −0.218
2.	Have	you	ever	had	asthma	in	your	opinion? +0.484 −0.484
3.	Have	you	ever	been	woken	at	night	by	an	attack	of	symptoms? +0.129 −0.129
4.	Are	your	symptoms	occur	or	worsen	in	a	seasonal	pattern? −0.141 +0.141
5.	Are	your	symptoms	occur	or	worsen	in	springs? +0.122 −0.122
6.	Have	your	symptoms	occur	or	worsen	in	the	presence	of	respiratory	viral	infections? +0.106 −0.106
7.	Have	your	symptoms	occur	or	worsen	in	the	presence	of	vehicles	smoke? −0.124 +0.124
8.	Have	you	ever	had	cough	and	phlegm	more	than	3	months	per	year	in	more	than	2	years? −0.309 +0.309
9.	Do	you	often	have	exertional	dyspnea? −0.112 +0.112
Total	score	(summation	of	the	coefficients	by	responses)**
*Coefficients	are	getting	by	regression	analysis;	**If	the	questionnaire	score	is	≥	−0.14	then	asthma	is	highly	suggested
Table 3. Demographic characteristics of cases with chronic dyspnea and comparison of them by disease
Asthma
(112)
Not asthma All cases
(208)
P-value
Bronchiec-
tasis
(48)
Fibrosis
(12)
COPD
(36)
Total
(96)
Age	mean
(SD)
48.9
(13.9)
43.4
(16.7)
55.1
(18.8)
62.4
(15.7)
52
(18.7)
50.3
(16.3)
0.195
Disease	duration	mean	
(SD)
9.6
(8.2)
17.8
(16.5)
4.8
(5.3)
9.1
(11.3)
12.9
(14.5)
11.2
(11.6)
0.055
Gender Male 50
(44.6%)
32
(66.7%)
8
(66.7%)
30
(83.3%)
70
(72.9%)
120
(57.7%)
<	0.001*
Female 61
(55.4%)
16
(33.3%)
4
(33.3%)
6
(16.7%)
26
(27.1%)
88
(42.3%)
Smoking Smoker 5
(4.5%)
5
(10.4%)
1
(8.3%)
11
(30.6%)
17
(17.7%)
22
(10.6%)
0.002*
Passive		
smoker
17
(15.2%)
10
(20.8%)
1
(8.3%)
2
(5.6%)
13
(13.5%)
30
(14.4%)
Ex-smoker 14
(12.5%)
4
(8.3%)
2
(16.7%)
14
(38.9%)
20
(20.8%)
34
(16.3%)
Non	smoker 76
(67.9%)
29
(60.4%)
8
(66.7%)
9
(25%)
46
(47.9%)
122
(58.7%)
Pack	×	year	
(SD)
20.4
(23)
22.9
(19.2)
7.6
(0.5)
34.3
(21.3)
29.1
(21.2)
26.1
(22)
0.179
*Difference	between	asthma	and	not	asthma	groups	was	statistically	significant.
COPD	—	chronic	obstructive	pulmonary	disease
Further analysis such as receiver operating charac-
teristic (ROC) curve (Figure 1) demonstrated that 
the 9-QQ had the score of ≥ −0.14 as a cut-off po-
int for diagnosis of asthma. 109 (97.3%) asthmatic 
patients and 22 (22.9%) non-asthmatic subjects 
suggested asthma in 9-QQ (P-value < 0.001). 
Finally, in patients with chronic dyspnea, in 
determining asthma, spirometric bronchodilator 
response had 48.2% sensitivity, 78.1% specifici-
ty, 62.01% accuracy, 2.2 and 0.66 positive and 
negative likelihood ratios. On the other hand, 
9-QQ had 97.3% sensitivity, 77.1% specificity, 
87.98% accuracy, 4.24 and 0.03 positive and ne-
gative likelihood ratios. Combination of both tests 
had 46.4% sensitivity, 94.8% specificity, 68.75% 
accuracy, 8.91 and 0.56 positive and negative 
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likelihood ratios, respectively. Their screening 
results and diagnostic values are reported in 
details in Table 4. 
Discussion
Asthma is a  common chronic condition 
without a  diagnostic gold standard for esta-
blishing the disease. Its diagnosis is often based 
on the patients’ symptoms, medical history, lung 
function measurements and/or provocation tests. 
Similar researches revealed that brief question-
naires are valuable in differentiating multiple 
pulmonary diseases from other pulmonary di-
sorders in primary health care centers [10, 11]. 
Also, there are various surveys in which asthma 
was defined by a questionnaire, but none of them 
are simple and accurate enough to be used in 
clinical practice, especially in our country. So, 
our goal was to collect questions with the best 
power to differentiate asthma from other diseases 
in one accurate, simple and easily applicable 
questionnaire. 
In the study, 208 cases with chronic dyspnea 
were assessed and their demographic findings 
were similar to other researches [10, 11, 14−22], 
such as the mean age of our cases was 50.3 (SD 
= 16.3) years — the same as 58.7 (SD = 11.4) in 
Tinkelman’s  study [11] and trivial differences 
were due to different study groups such as in 
Santos’s study [17] which was performed among 
5 to 15-years-old children. 
Diagnostic values of response to bronchodila-
tor in asthma in our study were similar to Mehrabi 
et al. report with sensitivity of 64% and specifi-
city of 60% (which is done in our country but 
only two groups of cases were assessed — COPD 
and asthmatic cases), and also the ones from the 
GINA’s study (sensitivity of 55% and specificity 
of 59%) [15]. In Jenkins et al. study, bronchial 
hyperresponsiveness had 39% sensitivity, 90% 
specificity, 55% positive predictive value, 82% 
negative predictive value in adults and 54% sen-
sitivity, 89% specificity, 64% positive predictive 
value, 85% negative predictive value in children 
[16]. So, it could be suggested that BHR in chil-
dren may be more sensitive than in adults, but 
specificities are the same. 
The 9-QQ in our study had 97.3% sensitivity, 
77.1% specificity, positive predictive value of 
83.2%, and negative predictive value of 96.1% 
and accuracy of 87.98%. Previous researches 
brought about variable results. Cunha and Santos 
conducted a study with a 4-question question-
naire and assessed its diagnostic values. They 
reported sensitivity of 17%, specificity of 89.6%, 
positive predictive value of 32%, negative pre-
dictive value of 79% and accuracy of 73.5% for 
this questionnaire [17]. So, our 9-QQ had the 
same accuracy as Santos questionnaire but had 
more sensitivity and less specificity. According to 
Table 4. Comparison of diagnostic values between response to bronchodilator in spirometry and questionnaire in determi-
ning asthma in patients with chronic dyspnea (asthma prevalence = 53.8%)
Variables Sen
95% CI
Spe
95% CI
PPV
95% CI 
NPV
95% CI
FPER
95% CI
FNER
95% CI
Acc
95% CI
PLR NLR
Bronchodilator	response 48.2%
38.7−57.8%
78.1%
68.3−85.7%
72%
60.3−81.5%
56.4%
47.5−64.9%
21.9%
14.3−31.7%
51.8%
42.2−61.3%
62.01%
55.4−68.6%
2.2 0.66
9-question	questionnaire 97.3%
91.8−99.3%
77.1%
67.2−84.8%
83.2%
75.5−89%
96.1%
88.3−99%
22.9%
15.2−32.8%
2.7%
0.7−8.2%
87.98%
83.5−92.4%
4.24 0.03
9-question	questionnaire	
+	bronchodilator	response
46.4%
37−56.1%
94.8%
87.7−98.1%
91.2%
80−96.7%
60.3%
52−68%
5.2%
1.9%−2.3%
53.6%
43.9−63%
68.75%
62.4−75%
8.91 0.56
95%	CI	—	95%	confidence	interval;		Acc	—	accuracy;		FNER	—	false	negative	error	rate;		FPER	—	false	positive	error	rate;		NLR	—	negative	likelihood	ratio;	NPV	—	
negative	predictive	value;		PLR	—	positive	likelihood	ratio;		PPV	—	positive	predictive	value;	Sen	—	sensitivity;	Spe	—	specificity
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Figure 1. Receiver	 operating	 characteristic	 curve	 of	 9-question	 qu-
estionnaire	to	determine	asthma	in	patients	with	chronic	dyspnea	
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differences in asthma prevalence in the studied 
populations (our cases were aged > 15 years and 
some were smokers with longer disease duration, 
but Santos’s cases were aged 5−15 years, nons-
mokers with shorter disease duration), PLR of 
our 9-QQ was more than Santos’s (4.24 vs 1.64), 
so, our 9-QQ works better than theirs in defining 
asthma among patients with chronic dyspnea. 
Jenkins and coworkers evaluated two question-
naires, the Tasmanian Asthma Survey (TAS) for 
adults and the International Study of Asthma and 
Allergies in childhood (ISAAC). They reported 80% 
and 85% sensitivities, 97% and 81% specificities, 
89% and 61% positive predictive values and 94% 
and 94% negative predictive values [16]. Venables 
et al. also discovered 91% sensitivity and 95% 
specificity for a 9-question questionnaire [18]. Our 
9-QQ had lower specificity than these questionna-
ires but other characteristics were found better. 
In a  review published by Toren et al., in 
articles with gold standard of clinical diagnosis, 
range of sensitivity was 48-100% with the average 
of 68%, and specificity was 78-100% with the 
average of 94% [19−22]. Sensitivity of our 9-QQ 
was more than their average, but specificity was 
slightly lower. 
Question 2 has the biggest score in 9-QQ; 
which reflects the patient’s opinion about his/her 
disease. This may be arising from insight of the 
subjects into their condition. Therefore, patients 
tend to research in the symptoms and pay more 
attention to them. So, one could say we may more 
relay on patients opinion in diagnosis of asthma. 
In regards of questions 4 and 5 in the 9-QQ, 
the same as other reports, our analysis revealed 
that bronchiectasis and COPD have worsened 
in winter [23, 24], and in our study, they had 
more prominent seasonal pattern than asthma, 
so, worsening of symptoms in seasonal pattern 
is against diagnosis of asthma in our 9-QQ. On 
the other hand, in some reports, asthma worsens 
during spring [25]. Our analysis also cleared that 
worsening of symptoms only during spring is in 
favor of asthma, which is reflected in question 5. 
Overall, our 9-QQ had acceptable sensitivity 
and specificity according to other articles, and 
could be used as a screening tool to distinguish 
between asthmatic cases and others with chronic 
dyspnea. It is important to emphasize that our 
questionnaire was used to differentiate asthma 
from other chronic respiratory disorders — not 
to screen the general population for diagnosing 
asthma. Similarly, we also evaluated the value of 
spirometry and bronchodilator response with this 
goal. According to Table 4, it is clear that 9-QQ 
is a better screening test than response to bron-
chodilator in lung function test for differentiating 
asthma from other chronic respiratory disorders 
which are characterized by chronic chough. Spe-
cificity, positive predictive value, false positive 
error rate and PLR improved together with com-
bination of both tests.
As Toren et al. reported [19], it seems that the 
combined use of questionnaire and spirometric 
response to bronchodilator is a proper method 
for detection of asthmatic patients. According 
to 97.3% sensitivity of 9-QQ, it can properly 
be used as a screening test, thus all cases with 
9-QQ’s score ≥ −0.14 are highly suspicious of 
having asthma. If there is an imperative need to 
confirm diagnosis, response to bronchodilator 
in spirometry is recommended in those with 
positive test to label a person as an asthmatic 
patient. But cases with negative test need more 
evaluation with provocative tests as methacholine 
or histamine challenge test. So, this approach may 
achieve the best screening results and decrease 
the need for spirometry, and could be cost-effec-
tive. More studies are needed to assess the costs. 
According to our findings, the use of the 
9-question questionnaire may be recommended 
to differentiate asthmatic patients from other in-
dividuals with chronic dyspnea for all health care 
units, clinics, polyclinics, and epidemiological 
screening researches. Also, it is recommended 
to use reversibility of airway obstruction to bron-
chodilator in spirometry, not as a screening but 
as a confirmatory test.
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